Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.
The deal has already been approved by the boards of directors from both companies.
Founded in 2009, Shockwave focuses on intravascular lithotripsy technology that uses sonic pressure waves to crack calcium lesions in arteries and restore blood flow. It’s similar to a technique used to break up kidney stones. The soundwave emitters are placed inside angioplasty catheters to reach the calcified areas of the artery.
Shockwave’s technology is used to treat coronary artery and peripheral artery disease.
The company’s revenue jumped 49% last year to $730 million.
Related articles:
Related suggestion:
Shanghai to build complete care system for children with autism by 2027IAEA warns that attacks on a nuclear plant in RussianAll Blacks center Jordie Barrett joining Leinster in DecemberChina's top legislature kickAbu Ghraib detainee shares emotional testimony during trial against Virginia military contractorThe pilots union at American Airlines says it's seeing more safety and maintenance issues'Goal' Palmer scores four in 6China's Han River sees first flood of 2024Married teacher caught naked in car with male student, 17, is the wife of HarvardNASA seeks faster, cheaper way to bring Mars samples to Earth
2.6451s , 6499.8359375 kb
Copyright © 2024 Powered by J&J to pump another $13B into its MedTech business with Shockwave deal ,Planet Pulse news portal